Tina Zecca, DO
Allergy & Immunology Physician in Little Silver, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,394 in Allergy & Immunology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Tina Zecca, DO reported a CMS MIPS final score of 77.2/100 - below the 83.1 national average - and filed 2,342 Medicare Part D claims in 2023.
- 77.2/100
- MIPS score · -6 vs avg
- 2K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Tina Zecca, DO's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
77 24th percentile higher than 24% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Tina Zecca, DO sits
This provider among allergy & immunology physician peers
Across the 740 allergy & immunology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Tina Zecca, DO writes more Part D claims than 90% of them and scores higher on MIPS quality than 44% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one allergy & immunology physician peer from a representative sample of 60; the gold marker is Tina Zecca, DO. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Tina Zecca, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Tina Zecca, DO?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Allergy & Immunology Physician compares to other specialties among New Jersey providers
Allergy & Immunology Physician ranks #122 among New Jersey's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the New Jersey provider total, by primary NUCC taxonomy. The highlighted bar is Allergy & Immunology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Tina Zecca, DO's 2023 MIPS final score plotted against the Allergy & Immunology Physician national average
- MIPS Final Score
- 77.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Allergy & Immunology Physician) - 77.2/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Allergy & Immunology Physician US NPIs
77.2/100 MIPS final score - 5.9 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Allergy & Immunology Physician. Quality dim: 91.4. Cost dim: 35.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Tina Zecca, DO appears in the CMS NPPES registry as an Allergy & Immunology Physician provider holding DO credentials at 200 WHITE RD, Little Silver, NJ, 07739, with a listed phone of (732) 741-8222. NPI 1790753630 was issued on 03/08/2006.
Medicare Part D records for calendar year 2023 show 2,342 prescription claims written by this provider, covering 371 Medicare beneficiaries and totaling roughly $927K in drug spend. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 77.2/100 for the 2023 performance year (Quality 91.4, Cost 35.4), compared with the national average of 83.1.
Allergy & Immunology Physician is a narrow specialty nationwide, with 3,394 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1790753630 |
|---|---|
| Specialty | Allergy & Immunology Physician |
| Credentials | DO |
| Gender | Female |
| NPI Issued | 03/08/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Tina Zecca, DO's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1790753630 is the unique 10-digit identifier CMS uses to link Zecca across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Tina Zecca, DO. Source: openpaymentsdata.cms.gov.
Total received
$50.7K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,765
- Total Day Supply
- 104,561
- Generic Drug Cost
- $101K
- Antibiotic Claims
- 161
Patient Demographics
- Average Patient Age
- 71.9 years
- Avg HCC Risk Score
- 1.02
- Gender Split
- 75% female / 25% male
- Age Distribution
- <65: 39, 65-74: 183, 75-84: 127, 85+: 22
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Tina Zecca, DO prescribes most
Top Medicare Part D drugs by claim count, 2023
- Montelukast Sodium
Montelukast Sodium
330 claims
- Azelastine Hcl
Azelastine Hcl
174 claims
- Levocetirizine Dih…
Levocetirizine Dihydrochloride
160 claims
- Prednisone 122
Prednisone
122 claims
- Trelegy Ellipta 115
Trelegy Ellipta
115 claims
- Albuterol Sulfate … 109
Albuterol Sulfate Hfa
109 claims
- Azelastine-Flutica… 98
Azelastine-Fluticasone
98 claims
- Symbicort 64
Symbicort
64 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 330 |
| Azelastine Hcl | 174 |
| Levocetirizine Dihydrochloride | 160 |
| Prednisone | 122 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 115 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 109 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 98 |
| Symbicort Budesonide/Formoterol Fumarate | 64 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 63 |
| Fluticasone Propionate | 62 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology Physician Overview
How Tina Zecca, DO fits within the Allergy & Immunology Physician landscape nationally.
Tina Zecca, DO's 2,342 claims are above the specialty average of 764.
Nearby Allergy & Immunology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Zecca.
Compare Allergy & Immunology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Allergy & Immunology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is Tina Zecca, DO's specialty? ▼
How much does Tina Zecca, DO prescribe under Medicare Part D? ▼
What is Tina Zecca, DO's Medicare quality score? ▼
Where is Tina Zecca, DO located? ▼
What is Tina Zecca, DO's NPI number? ▼
How many Allergy & Immunology Physician providers are there in the US? ▼
What drugs does Tina Zecca, DO prescribe most often? ▼
Does Tina Zecca, DO accept Medicare? ▼
How can I verify Tina Zecca, DO's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.